Skip to content

13F-HR filed by Alphabet Inc.

Alphabet Inc. filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-08, with 26 holding rows worth $4,015,568,781.

Accession
0001652044-26-000051
Filed
2026-05-08
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2026

A holdings report, 27 entries on the cover page, a total value of $4,015,568,781 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,015,568,781 with VALUE read as dollars as filed, 13F file number 028-22702. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CME Group Inc. Class A12572Q105COM3,484,020$1,029,005,307dollars as filed
PLANET LABS PBC72703X106COM CL A35,248,893$985,206,582dollars as filed
AST SPACEMOBILE INC COM CL A00217D100Stock8,943,486$741,146,685dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock3,292,525$320,198,056dollars as filed
ARM HOLDINGS PLC042068205SPONSORED ADS1,960,784$296,627,404dollars as filed
FRESHWORKS INC CLASS A COM358054104Stock16,206,643$130,139,343dollars as filed
UIPATH INC90364P105CL A7,034,337$78,081,141dollars as filed
TEMPUS AI INC CL A88023B103Stock1,551,102$70,140,832dollars as filed
PAYPAY CORP70450C101SPONSORED ADS3,125,000$66,687,500dollars as filed
GITLAB INC CLASS A COM37637K108Stock2,724,712$58,962,768dollars as filed
PRIME MEDICINE INC74168J101COM16,562,498$57,637,493dollars as filed
ETHOS TECHNOLOGIES INC29765A101CL A3,770,156$42,112,643dollars as filed
MAZE THERAPEUTICS INC COM578784100Stock1,388,583$41,449,203dollars as filed
BRIDGEBIO ONCOLOGY THERAPEUT107924102COM NEW2,823,126$25,266,978dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock1,564,173$15,563,521dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM684,275$11,256,324dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK241,264$9,706,051dollars as filed
SANA BIOTECHNOLOGY INC799566104COM2,812,500$8,100,000dollars as filed
BEAM THERAPEUTICS INC07373V105COM321,604$7,663,823dollars as filed
LYELL IMMUNOPHARMA INC COM NEW55083R203Stock293,256$5,882,715dollars as filed
OSCAR HEALTH INC687793109CL A481,988$5,528,402dollars as filed
FIGMA INC CL A316841105COM215,582$4,557,403dollars as filed
SPERO THERAPEUTICS INC84833T103COM889,979$2,082,551dollars as filed
HYPERFINE INC44916K106Common Stock898,720$970,618dollars as filed
AUTOLUS THERAPEUTICS PLC SPON05280R100COM698,262$963,602dollars as filed
TENAYA THERAPEUTICS INC87990A106COM915,705$631,836dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001652044-26-000051this filing2026-05-08acceptance time not in the bulk data set